In MS Mice, Lipid Signaling Molecule S1P Regulates Immune Responses multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.
Rising Temperatures Could Lead to Greater Care Needs for MS Patients 4.6 (12)
Rising average temperatures may lead to a worsening of symptoms in people with multiple sclerosis (MS) and a greater need for hospital care, according to a preliminary study by researchers in the U.S.
“Our study suggests that warming trends could have serious health implications over the long term for people living with MS,” Holly Elser, PhD, an epidemiologist at Stanford University School of Medicine in California and a study author, said in a press release.
Many people with MS experience a temporary worsening of symptoms, such as fatigue or weakness, when they overheat in hot weather. These changes are linked to heat sensitivity, and can result from slight increases in core body temperature that further affect the ability of nerves to conduct electrical impulses, especially if the nerve fibers are damaged as happens in MS.
Click here to subscribe to the Multiple Sclerosis News Today Newsletter! 4.5 (2)
Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference.
Women with multiple sclerosis (MS) who continue taking disease-modifying therapies (DMTs) throughout pregnancy accrue lower non-maternity healthcare costs related to hospitalization, new research shows.
Overall, the adjusted medical costs for patients who were consistently taking all of their medications were lowered by as much as $4,383, an analysis found.
According to the National MS Society, no DMTs are currently approved for use during pregnancy however, stopping treatment can increase the risk of relapses and associated health problems for people with MS.
Click here to subscribe to the Multiple Sclerosis News Today Newsletter! 4.7 (32)
Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference.
Cognitive impairment without physical disability in multiple sclerosis (MS) may grow in prevalence as newer therapies better control patients’ motor symptoms.
But the “cognitive-predominant” MS that is likely to be increasingly evident will be a greater challenge to identify and treat, and should now be a clinical and research priority, an analysis study reports.
Findings from this analysis, led by Claire Riley, MD, a professor of neurology at Columbia University, were presented by Riley at the ACTRIMS Forum 2021, in the talk “Cerebral/Cognitive-Predominant MS.”